Clinical Trial Update: SystemIc iNflammation and Microvascular diSease PreventIon in psoRiatic diseasE [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial exploring systemic inflammation and microvascular disease prevention in psoriasis and psoriatic arthritis has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis
• Psoriatic Arthritis

Snippet

Sponsor: Brigham and Women's Hospital | Conditions: Psoriasis, Psoriatic Arthritis | Phase 4 | Status: WITHDRAWN